Saint Thomas Health

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Aortic stenosis4 trials
• Atrial fibrillation3 trials
• Heart failure3 trials
• Stroke2 trials
• Amyloidosis1 trial
• Hypertrophic cardiomyopathy1 trial

Phase

• Phase 33 trials

Status

• Recruiting5 trials
• Active, not recruiting4 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Edwards Lifesciences5 trials
• Boston Scientific Corporation2 trials
• Janssen Research & Development, LLC2 trials
• Bristol-Myers Squibb1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

  NCT05172973· Edwards Lifesciences· Source

  Contact: Edwards THV Clinical Affairs

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  NCT05489705· Bristol-Myers Squibb· Source

  Contact: Mark Zenker, Site 0019

• Recruiting

  ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

  NCT05172960· Edwards Lifesciences· Source

  Contact: Edwards THV Clinical Affairs

• Recruiting

  PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

  NCT04889872· Edwards Lifesciences· Source

  Contact: Edwards THV Clinical Affairs

• Active, not recruiting

  TRISCEND II Pivotal Trial

  NCT04482062· Edwards Lifesciences· Source

• Active, not recruiting

  ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis

  NCT03517436· Edwards Lifesciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic stenosis3 recruiting
• Heart failure2 recruiting
• Amyloidosis1 recruiting
• Hypertrophic cardiomyopathy1 recruiting

Closed trials

• Completed

  Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

  NCT03795298· Boston Scientific Corporation· Source

• Terminated

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Boston Scientific Corporation· Source